The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Zhihua Liu sits on this spectrum.
This scientist: 384 publications — 89th percentile
89% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 1,028 publications or more.
The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Zhihua Liu sits on this spectrum.
This scientist: 73 D-Index — 71st percentile
71% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 167 D-Index or more.
Zhihua Liu is affiliated with Peking Union Medical College Hospital in China. Their research encompasses diverse areas within biochemistry, genetics, molecular biology, and medicine, with a particular focus on oncology and cancer research. This scholar's work covers notable subfields such as molecular biology, oncology, cancer research, biomedical engineering, and immunology.
Their research themes concentrate on specific topics including RNA modifications and cancer, cancer-related gene regulation, epigenetics and DNA methylation, cancer immunotherapy and biomarkers, esophageal cancer research and treatment, ubiquitin and proteasome pathways, and cancer-related molecular mechanisms research.
Zhihua Liu has contributed to multiple publications in various esteemed journals. Frequent publication venues include:
Among their recent papers are:
Zhihua Liu frequently collaborates with several co-authors, including:
Their scientific output amounts to a substantial number of publications, especially in molecular biology and medicine, involving 236 and 140 papers respectively. The body of work reflects an interdisciplinary approach, combining insights from molecular biology, immunology, biomedical engineering, and clinical oncology.
This extensive research portfolio indicates an emphasis on understanding cancer mechanisms at the molecular and cellular level, with applications in immunotherapy and treatment strategies, particularly concerning esophageal and other cancers.
Yongmei Song;Lin Li;Yunwei Ou;Zhibo Gao
Jinlin Hou;Zhihua Liu;Fan Gu
De-Zhong Xu;Yong-Ping Yan;Bernard C.K. Choi;Jian-Qiu Xu
Yuanyuan Zhang;Hongyan Chen;Hongnan Mo;Xueda Hu
Yanyan Tian;Aiping Luo;Yiran Cai;Qin Su
Chen Wu;Zhibin Hu;Zhonghu He;Weihua Jia
Xuemei Zhang;Xuemei Zhang;Xiaoping Miao;Wen Tan;Baitang Ning
Chen Wu;Chen Wu;Peter Kraft;Kan Zhai;Jiang Chang
Aiping Luo;Jianping Kong;Gengxi Hu;Choong Chin Liew
Hongyan Chen;Chengshan Xu;Qing'e Jin;Zhihua Liu
S Yang;Y Li;J Gao;T Zhang
Yuan Hong;Xiaoping Miao;Xuemei Zhang;Fang Ding
Tong Tong;Yali Zhong;Jianping Kong;Lijia Dong
Jiang Chang;Wenle Tan;Zhiqiang Ling;Ruibin Xi
Xuantong Zhou;Min You;Fuhui Wang;Zhenzhen Wang
Zhihua Liu;Jinlin Hou
Gui Zhen Wang;Li Zhang;Xin Chun Zhao;Xin Chun Zhao;San Hui Gao
Chen Wu;Zhaoming Wang;Zhaoming Wang;Xin Song;Xin Song;Xiao-Shan Feng
Yongping Cui;Hongyan Chen;Ruibin Xi;Heyang Cui;Heyang Cui
Tong Tong;Junfang Ji;Shunqian Jin;Shunqian Jin;Xianxing Li
If you think any of the details on this page are incorrect, let us know.
University of California, Davis
Montana State University
Instituto de Salud Pública de Navarra
University of Pennsylvania
University of Illinois at Urbana-Champaign
New York University
Friedrich Schiller University Jena
Texas A&M University
National Technological University
University of Southampton
Rensselaer Polytechnic Institute
Linköping University
University of Minnesota
Texas A&M University
Mount Sinai Health System
Harvard University
